Galena Biopharma (GALE) Reports NeuVax Phase 3, PRESENT Achieves Qualifying DFS Events
Tweet Send to a Friend
Galena Biopharma, Inc. (Nasdaq: GALE) announced that the 70th qualifying disease free survival (DFS) event has been achieved in the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
